MRI scan 'better' for heart patients
December 23, 2011 in CardiologyA magnetic resonance imaging (MRI) scan for coronary heart disease is better than the most commonly-used alternative, a major UK trial of heart disease patients has shown.
The findings by University of Leeds researchers could change the way that people with suspected heart disease are assessed, potentially avoiding the need for tests that are invasive or use ionising radiation.
Full results of the study, which was funded by a £1.3 million grant from the British Heart Foundation (BHF), are published online today by the Lancet medical journal.
Coronary heart disease (CHD) is a leading cause of death and disability worldwide. In the US, an estimated 18 million men and women are living with the condition, resulting in an estimated cost to the economy of $177.1 billion in 2010.
CHD is caused when vital arteries serving the heart become narrowed or blocked by a build-up of fatty substances. This can lead to severe chest pain, known as angina, and if the condition worsens and remains untreated, patients may have a heart attack.
Patients with chest pain who are suspected of having angina will typically be sent to hospital for further tests. These tests will confirm the diagnosis of CHD and help doctors decide on the best course of treatment, which may involve drug therapy, a balloon 'stretch and stent' procedure to open-up narrowings in the heart's blood vessels - or a heart bypass operation.
At the moment, patients with suspected angina are most likely to have either an angiogram - an invasive test where dye is injected directly into the heart's arteries or a non-invasive imaging test called SPECT. Unlike MRI scans, angiograms and SPECT tests both involve ionising radiation.
A five-year study by University of Leeds researchers, involving 752 patients, has now shown that an MRI scan is a reliable way of detecting signs of significant CHD. The researchers also showed that MRI was better than SPECT at diagnosing CHD and at ruling out heart disease in patients who did not have the condition.
This is the first time that MRI has been compared head-to-head against the 'gold standard' tests for CHD in such a large group of patients. The results may now lead healthcare policy-makers to re-think guidance on the tests that patients with suspected CHD should be offered.
University of Leeds' Dr John Greenwood, who led the study, said: "We have shown convincingly that of the options available to doctors in diagnosing coronary heart disease, MRI is better than the more commonly-used SPECT imaging test. As well as being more accurate, it has the advantage of not using any ionising radiation, sparing patients and health professionals from unnecessary exposure."
"The MRI technique could be used widely and not just in the UK," Dr Greenwood added. "The scans were all carried out on a standard 1.5 Tesla scanner exactly the type of MRI scanner that you would find in most hospitals today."
Professor Peter Weissberg, Medical Director at the British Heart Foundation, said: "For patients suffering with chest pains, there are a number of tests that can be used to decide whether their symptoms are due to coronary heart disease or not. This research shows that a full MRI scan is better than the most commonly used alternative - a SPECT scan using a radioactive tracer.
"MRI has the additional advantage that it doesn't involve radiation. At present, not all hospitals have the expertise to undertake such scans but these findings provide clear evidence that MRI should be more widely used in the future."
More information: Research published Online First in the "Lancet:" "CE-MARC: A Prospective Evaluation of Cardiovascular Magnetic Resonance and Single-Photon Emission Computed Tomography in Coronary Heart Disease" by Greenwood et al, DOI:10.1016/S0140-6736(11)61335-4
Provided by
University of Leeds
-
New heart scan may speed up diagnosis with less radiation
Aug 23, 2011 |
not rated yet |
0
-
New tool to rule out coronary heart disease in primary care
Jul 05, 2010 |
not rated yet |
0
-
FDA clears Siemens' 2-in-1 medical scanner
Jun 10, 2011 |
not rated yet |
0
-
FDA approval for Siemens PET Scan - MRI combo
Jun 13, 2011 |
not rated yet |
0
-
Hospital heart attack death rates improving but very elderly still missing out
Oct 19, 2011 |
not rated yet |
0
-
Of mice and mental models: Neuroscientific implications of risk-optimized behavior in the mouse
May 25, 2012 |
not rated yet |
0
-
Limits to growth: Scientists identify key metastasis-enabling enzyme
May 22, 2012 |
5 / 5 (4) |
0
-
Seeing is as seeing does: Spatially-structured retinal input in early development of cortical maps
Apr 26, 2012 |
5 / 5 (4) |
1
-
Dreamless nights: Brain activity during nonrapid eye movement sleep
Apr 09, 2012 |
4.4 / 5 (12) |
0
-
Take your time: Neurobiology sheds light on the superiority of spaced vs. massed learning
Mar 28, 2012 |
4.5 / 5 (21) |
3
-
Force in a magnetic coupling
9 hours ago
-
Sign of scalar product in electric potential integral?
16 hours ago
-
Heat engines: how can we yield work?
17 hours ago
-
Work done by us on the spring
May 25, 2012
-
Surface current density
May 25, 2012
-
Work done on body moving in a circle
May 25, 2012
- More from Physics Forums - Classical Physics
More news stories
One-fifth of healthy middle-aged men have low-grade murmur
(HealthDay) -- More than one-fifth of healthy middle-aged men have a low-grade systolic heart murmur that confers a nearly five-fold higher risk of future aortic valve replacement (AVR), according to a study ...
Cardiology
May 25, 2012 |
not rated yet |
0
New device allows pacemaker patients to safely undergo MRIs
For many, it's a medical conundrum: The very pacemaker keeping their heart in rhythm prevents them from undergoing an MRI to diagnose other ailments, because interaction between the two devices could prove deadly.
Cardiology
May 25, 2012 |
not rated yet |
0
|
New study should end debate over magnesium treatment for preventing poor outcome after haemorrhagic stroke
An international randomised trial and meta-analysis published Online First in The Lancet should put an end to the debate about the use of intravenous magnesium sulphate to prevent poor outcomes after haemorrhagic stroke. The in ...
Cardiology
May 25, 2012 |
not rated yet |
0
Low vitamin D in diet increases stroke risk in Japanese-Americans
Japanese-American men who did not eat foods rich in vitamin D had a higher risk of stroke later in life, according to results of a 34-year study reported in Stroke, an American Heart Association journal.
Cardiology
May 24, 2012 |
not rated yet |
0
Clot buster seems to help up to 6 hours after stroke
(HealthDay) -- The largest study of its kind finds that stroke patients benefit from a clot-busting drug even six hours after a stroke, suggesting that the current recommended 4.5-hour limit could be expanded.
Cardiology
May 24, 2012 |
not rated yet |
0
Travel to high altitudes tied to Crohn's, colitis flare-ups
(HealthDay) -- People with inflammatory bowel disease, which includes Crohn's disease and colitis, may be at increased risk for flare-ups when they fly or travel to high altitudes for skiing or mountain climbing, ...
Family history of Alzheimer's affects functional connectivity
(HealthDay) -- Cognitively normal individuals with a family history of late-onset Alzheimer's disease (AD) may display lower resting state functional connectivity in the default mode network (DMN) of the brain, ...
Transvaginal mesh op restores pelvic organ prolapse at price
(HealthDay) -- Transvaginal mesh (TVM) procedures are effective for anatomical restoration of pelvic organ prolapse (POP), but patients report a worsening of sexual function following surgery, according to ...
Of mice and mental models: Neuroscientific implications of risk-optimized behavior in the mouse
(Medical Xpress) -- Regardless of an organism’s biological complexity, every encephalized animal continuously makes under-informed behavioral choices that can have serious consequences. Despite its ubiquity, ...
Weight struggles? Blame new neurons in your hypothalamus
New nerve cells formed in a select part of the brain could hold considerable sway over how much you eat and consequently weigh, new animal research by Johns Hopkins scientists suggests in a study published in the May issue ...
Thioridazine kills cancer stem cells in human while avoiding toxic side-effects of conventional cancer treatments
A team of scientists at McMaster University has discovered a drug, thioridazine, successfully kills cancer stem cells in the human while avoiding the toxic side-effects of conventional cancer treatments.